BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 27665733)

  • 1. Programmed death-1
    Singh A; Mohan A; Dey AB; Mitra DK
    Clin Exp Immunol; 2017 Feb; 187(2):269-283. PubMed ID: 27665733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1 modulating Mycobacterium tuberculosis-specific polarized effector memory T cells response in tuberculosis pleurisy.
    Li J; Jin C; Wu C; Huang J
    J Leukoc Biol; 2019 Sep; 106(3):733-747. PubMed ID: 30861206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting the programmed death 1 pathway rescues Mycobacterium tuberculosis-specific interferon γ-producing T cells from apoptosis in patients with pulmonary tuberculosis.
    Singh A; Mohan A; Dey AB; Mitra DK
    J Infect Dis; 2013 Aug; 208(4):603-15. PubMed ID: 23661793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis.
    Sharma PK; Saha PK; Singh A; Sharma SK; Ghosh B; Mitra DK
    Am J Respir Crit Care Med; 2009 Jun; 179(11):1061-70. PubMed ID: 19246720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium tuberculosis Specific CD8
    Suarez GV; Melucci Ganzarain CDC; Vecchione MB; Trifone CA; Marín Franco JL; Genoula M; Moraña EJ; Balboa L; Quiroga MF
    Sci Rep; 2019 Jan; 9(1):187. PubMed ID: 30655556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed death-1 receptor suppresses γ-IFN producing NKT cells in human tuberculosis.
    Singh A; Dey AB; Mohan A; Mitra DK
    Tuberculosis (Edinb); 2014 May; 94(3):197-206. PubMed ID: 24629634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1 Expression on
    Day CL; Abrahams DA; Bunjun R; Stone L; de Kock M; Walzl G; Wilkinson RJ; Burgers WA; Hanekom WA
    Front Immunol; 2018; 9():1995. PubMed ID: 30233588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment.
    Hassan SS; Akram M; King EC; Dockrell HM; Cliff JM
    PLoS One; 2015; 10(9):e0137646. PubMed ID: 26359860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.
    Jurado JO; Alvarez IB; Pasquinelli V; Martínez GJ; Quiroga MF; Abbate E; Musella RM; Chuluyan HE; García VE
    J Immunol; 2008 Jul; 181(1):116-25. PubMed ID: 18566376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L2
    Tavukcuoglu E; Horzum U; Yilmaz KB; Esendagli G
    Immunol Cell Biol; 2020 Feb; 98(2):152-164. PubMed ID: 31845380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1/PD-L pathway inhibits M.tb-specific CD4
    Shen L; Gao Y; Liu Y; Zhang B; Liu Q; Wu J; Fan L; Ou Q; Zhang W; Shao L
    Sci Rep; 2016 Dec; 6():38362. PubMed ID: 27924827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-γ Recall Response by Splenic CD4⁺ Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B.
    Riccomi A; Palma C
    PLoS One; 2015; 10(9):e0137783. PubMed ID: 26379242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection.
    Pollock KM; Montamat-Sicotte DJ; Grass L; Cooke GS; Kapembwa MS; Kon OM; Sampson RD; Taylor GP; Lalvani A
    PLoS One; 2016; 11(1):e0146905. PubMed ID: 26756579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis B e antigen from chronic hepatitis B patients induces Th1/Th2 cytokine imbalance in vitro].
    Han YP; Li J; Jiang LF; Xu QQ; Liu B; Dong L; Chen N; Kong LH; Xie FR; Huang ZH
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):584-9. PubMed ID: 24119737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis.
    Alvarez IB; Pasquinelli V; Jurado JO; Abbate E; Musella RM; de la Barrera SS; García VE
    J Infect Dis; 2010 Aug; 202(4):524-32. PubMed ID: 20617899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in
    Liu Q; Ou Q; Shen L; Qiu C; Zhang B; Zhang W; Shao L; Gao Y; Chen ZW
    Front Immunol; 2019; 10():2430. PubMed ID: 31681314
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progress in PD-1/PD-L1, PD-L2 signaling pathway and its role in host anti-tuberculosis immunity].
    Yu XW; Zhang JA; Xie JP
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 May; 47(5):485-489. PubMed ID: 38706074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
    Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S
    J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of programmed cell death-1 and its ligand B7 homolog 1 in peripheral blood lymphocytes from patients with peripartum cardiomyopathy.
    Xia G; Zheng X; Yao X; Yao X; Liu Z; Wang J
    Clin Cardiol; 2017 May; 40(5):307-313. PubMed ID: 28026044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis.
    Che YM; Zhang Y; Li M; Li XP; Zhang LL
    J Cell Biochem; 2018 Apr; 119(4):3044-3057. PubMed ID: 29058791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.